197 related articles for article (PubMed ID: 34769873)
1. In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
Rehman A; Wang X; Ahmad S; Shahid F; Aslam S; Ashfaq UA; Alrumaihi F; Qasim M; Hashem A; Al-Hazzani AA; Abd Allah EF
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769873
[No Abstract] [Full Text] [Related]
2. Potential Therapeutic Candidates against
Kadi RH; Altammar KA; Hassan MM; Shater AF; Saleh FM; Gattan H; Al-Ahmadi BM; AlGabbani Q; Mohammedsaleh ZM
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742569
[No Abstract] [Full Text] [Related]
3. In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
Shami A; Alharbi NK; Al-Saeed FA; Alsaegh AA; Al Syaad KM; Abd El-Rahim IHA; Mostafa YS; Ahmed AE
Life (Basel); 2023 May; 13(5):. PubMed ID: 37240772
[No Abstract] [Full Text] [Related]
4. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis.
Singh S; Singh DB; Singh A; Gautam B; Ram G; Dwivedi S; Ramteke PW
Interdiscip Sci; 2016 Dec; 8(4):388-394. PubMed ID: 26750924
[TBL] [Abstract][Full Text] [Related]
5. Integrated Pangenome Analysis and Pharmacophore Modeling Revealed Potential Novel Inhibitors against
Almuhayawi MS; Al Jaouni SK; Selim S; Alkhalifah DHM; Marc RA; Aslam S; Poczai P
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429532
[No Abstract] [Full Text] [Related]
6. Identification and prioritization of promising lead molecules from
Mangal P; Jha RK; Jain M; Singh AK; Muthukumaran J
J Biomol Struct Dyn; 2023; 41(12):5418-5435. PubMed ID: 35706070
[TBL] [Abstract][Full Text] [Related]
7. Subtractive genomics and molecular docking approach to identify drug targets against Stenotrophomonas maltophilia.
Saleem H; Ashfaq UA; Nadeem H; Zubair M; Siddique MH; Rasul I
PLoS One; 2021; 16(12):e0261111. PubMed ID: 34910751
[TBL] [Abstract][Full Text] [Related]
8. Systematic identification and repurposing of FDA-approved drugs as antibacterial agents against Streptococcus pyogenes: In silico and in vitro studies.
Gracia J; Perumal D; Dhandapani P; Ragunathan P
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128667. PubMed ID: 38101681
[TBL] [Abstract][Full Text] [Related]
9. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
11. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
12. Proteome based mapping and molecular docking revealed DnaA as a potential drug target against
Shahid F; Alghamdi YS; Mashraqi M; Khurshid M; Ashfaq UA
Saudi J Biol Sci; 2022 Feb; 29(2):1147-1159. PubMed ID: 35241965
[No Abstract] [Full Text] [Related]
13. Molecular modeling and simulation of FabG, an enzyme involved in the fatty acid pathway of Streptococcus pyogenes.
Shafreen RB; Pandian SK
J Mol Graph Model; 2013 Sep; 45():1-12. PubMed ID: 23988477
[TBL] [Abstract][Full Text] [Related]
14. Differential compartmentalization of Streptococcus pyogenes virulence factors and host protein binding properties as a mechanism for host adaptation.
Kilsgård O; Karlsson C; Malmström E; Malmström J
Int J Med Microbiol; 2016 Nov; 306(7):504-516. PubMed ID: 27423808
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Mass Spectrometric Survey of Streptococcus pyogenes Subcellular Proteomes.
Wilk L; Happonen L; Malmström J; Herwald H
J Proteome Res; 2018 Jan; 17(1):600-617. PubMed ID: 29160079
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling on streptolysin-O of multidrug resistant Streptococcus pyogenes and computer aided screening and in vitro assay for novel herbal inhibitors.
Skariyachan S; Narayan NS; Aggimath TS; Nagaraj S; Reddy MS; Narayanappa R
Curr Comput Aided Drug Des; 2014 Mar; 10(1):59-74. PubMed ID: 24694051
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential universal vaccine candidates against group A Streptococcus by using high throughput in silico and proteomics approach.
Sharma A; Arya DK; Sagar V; Bergmann R; Chhatwal GS; Johri AK
J Proteome Res; 2013 Jan; 12(1):336-46. PubMed ID: 23181284
[TBL] [Abstract][Full Text] [Related]
18. Protocol for Proteome Analysis of Group A Streptococcus.
Wilk L
Methods Mol Biol; 2020; 2136():135-144. PubMed ID: 32430817
[TBL] [Abstract][Full Text] [Related]
19. Predicting Promiscuous T Cell Epitopes for Designing a Vaccine Against Streptococcus pyogenes.
Ebrahimi S; Mohabatkar H; Behbahani M
Appl Biochem Biotechnol; 2019 Jan; 187(1):90-100. PubMed ID: 29948995
[TBL] [Abstract][Full Text] [Related]
20. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
